106 related articles for article (PubMed ID: 16479604)
1. Cyclin D1 and p21 is elevated in the giant cells of giant cell tumors.
Kandel R; Li SQ; Bell R; Wunder J; Ferguson P; Kauzman A; Diehl JA; Werier J
J Orthop Res; 2006 Mar; 24(3):428-37. PubMed ID: 16479604
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis.
Matsubayashi S; Nakashima M; Kumagai K; Egashira M; Naruke Y; Kondo H; Hayashi T; Shindo H
Pathol Res Pract; 2009; 205(9):626-33. PubMed ID: 19324500
[TBL] [Abstract][Full Text] [Related]
3. Cyclin alterations in giant cell tumor of bone.
Kauzman A; Li SQ; Bradley G; Bell RS; Wunder JS; Kandel R
Mod Pathol; 2003 Mar; 16(3):210-8. PubMed ID: 12640100
[TBL] [Abstract][Full Text] [Related]
4. YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor.
Chiang WC; Teng CM; Lin SL; Chen YM; Tsai TJ; Hsieh BS
Eur J Pharmacol; 2005 Jul; 517(1-2):1-10. PubMed ID: 15950964
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle regulators in bladder cancer: relationship to schistosomiasis.
Eissa S; Ahmed MI; Said H; Zaghlool A; El-Ahmady O
IUBMB Life; 2004 Sep; 56(9):557-64. PubMed ID: 15590562
[TBL] [Abstract][Full Text] [Related]
6. Frequent upregulation of cyclin D1 and p16 expression with low Ki-67 scores in multinucleated giant cells.
Choi JW; Lee JH; Kim YS
Pathobiology; 2011; 78(4):233-7. PubMed ID: 21778791
[TBL] [Abstract][Full Text] [Related]
7. Cell Cycle Regulatory Protein Expression in Multinucleated Giant Cells of Giant Cell Tumor of Bone: do They Proliferate?
Maros ME; Balla P; Micsik T; Sapi Z; Szendroi M; Wenz H; Groden C; Forsyth RG; Picci P; Krenacs T
Pathol Oncol Res; 2021; 27():643146. PubMed ID: 34257609
[TBL] [Abstract][Full Text] [Related]
8. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.
Suzui M; Masuda M; Lim JT; Albanese C; Pestell RG; Weinstein IB
Cancer Res; 2002 Jul; 62(14):3997-4006. PubMed ID: 12124333
[TBL] [Abstract][Full Text] [Related]
9. Recurrence of giant cell tumour of bone: role of p53, cyclin D1, β-catenin and Ki67.
Lujic N; Sopta J; Kovacevic R; Stevanovic V; Davidovic R
Int Orthop; 2016 Nov; 40(11):2393-2399. PubMed ID: 27658412
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
[TBL] [Abstract][Full Text] [Related]
11. Giant cell tumour of bone: morphological, biological and histogenetical aspects.
Werner M
Int Orthop; 2006 Dec; 30(6):484-9. PubMed ID: 17013643
[TBL] [Abstract][Full Text] [Related]
12. Giant cell tumors of the bone: molecular profiling and expression analysis of Ephrin A1 receptor, Claudin 7, CD52, FGFR3 and AMFR.
Guenther R; Krenn V; Morawietz L; Dankof A; Melcher I; Schaser KD; Kasper HU; Kuban RJ; Ungethüm U; Sers C
Pathol Res Pract; 2005; 201(10):649-63. PubMed ID: 16325507
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
14. Cell cycle-dependent expression of cyclin D1 and a 45 kD protein in human A549 lung carcinoma cells.
Wu F; Bui KC; Buckley S; Warburton D
Am J Respir Cell Mol Biol; 1994 Apr; 10(4):437-47. PubMed ID: 8136159
[TBL] [Abstract][Full Text] [Related]
15. Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity.
Dong J; Peng J; Zhang H; Mondesire WH; Jian W; Mills GB; Hung MC; Meric-Bernstam F
Cancer Res; 2005 Mar; 65(5):1961-72. PubMed ID: 15753396
[TBL] [Abstract][Full Text] [Related]
16. [Expression and significance of urokinase-type plasminogen activator, its receptor, and type 2 inhibitor in giant cell tumor of bone].
Li H; Dong S; Zeng Y
Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):386-8. PubMed ID: 11810768
[TBL] [Abstract][Full Text] [Related]
17. Euphol arrests breast cancer cells at the G1 phase through the modulation of cyclin D1, p21 and p27 expression.
Wang L; Wang G; Yang D; Guo X; Xu Y; Feng B; Kang J
Mol Med Rep; 2013 Oct; 8(4):1279-85. PubMed ID: 23969579
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of cell cycle regulatory proteins in benign and malignant bone and soft tissue neoplasms.
Bui MM; Bagui TK; Boulware DC; Letson DG; Nasir A; Kaiser HE; Pledger WJ; Coppola D
In Vivo; 2007; 21(5):729-37. PubMed ID: 18019405
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.
Lau YS; Sabokbar A; Gibbons CL; Giele H; Athanasou N
Hum Pathol; 2005 Sep; 36(9):945-54. PubMed ID: 16153456
[TBL] [Abstract][Full Text] [Related]
20. The role of KLF4 in UVB-induced murine skin tumor development and its correlation with cyclin D1, p53, and p21(Waf1/Cip1) in epithelial tumors of the human skin.
Choi WJ; Youn SH; Back JH; Park S; Park EJ; Kim KJ; Park HR; Kim AL; Kim KH
Arch Dermatol Res; 2011 Apr; 303(3):191-200. PubMed ID: 21132436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]